Gladiolus (Gladiolus ×hybridus) is an asexually propagated, herbaceous perennial and an economically important cut flower crop. In commercial production, gladioli have tall flower stalks, which limit their use to cut flowers and annual garden plants. The gladiolus breeding program at the University of Minnesota has bred and selected rapid generation cycling (RGC) cycle 1 gladiolus, which can flower in <1 year from seed instead of the norm of 3 to 5 years (which are vegetatively propagated as corms). Gibberellin inhibitors, such as ancymidol, are used as plant growth retardants to control height in potted plants. Higher concentrations can inhibit flowering along with other negative side effects. The aim of this study was to investigate the growth, flowering, and corm/cormel production response of cycle 1 gladiolus to the gibberellin inhibitor, ancymidol (0, 100, and 400 mg·L−1 soak) in comparison with noncycle 1 genotypes and commercial cultivars for potted gladiolus production. Cycle 1 genotypes flowered with all ancymidol concentrations while noncycle 1 genotypes had significantly fewer flowers or were completely nonflowering under higher concentrations. All tested genotypes had increased leaf width as ancymidol concentration increased. Conversely, flower stalk heights were shorter as the ancymidol concentration increased while the number of stalks was nonsignificant. Corms, cormel number, and fresh weights decreased in all genotypes except for one cycle 1 genotype, which had an increase in both corm number and fresh weight when treated with 100 mg·L−1 ancymidol. Cycle 1 gladiolus are more resilient to this gibberellin inhibitor even at high concentrations and can potentially be used for gladiolus potted plant production.
Read full abstract